Reuters logo
in 4 months
BRIEF-Galectin Therapeutics drug demonstrates clinically significant effect in eczema patients
March 14, 2017 / 1:11 PM / in 4 months

BRIEF-Galectin Therapeutics drug demonstrates clinically significant effect in eczema patients

1 Min Read

March 14 (Reuters) - Galectin Therapeutics Inc:

* Galectin Therapeutics Inc - GR-MD-02 demonstrates clinically significant effect in patients with severe and refractory atopic dermatitis (eczema)

* Galectin Therapeutics Inc - there were no serious adverse events observed Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below